Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .

Laurus Labs Ltd - 540222 - Update On Our Disclosure Dated April 25, 2024 Regarding The Appointment Of Directors.

Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Laurus Labs (LAURUS IN)

Laurus Labs Ltd - 540222 - Update On Our Disclosure Dated April 25, 2024 Regarding The Appointment Of Directors.

Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of SEBI LODR

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)